ADRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for ADRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADS031, a histamine H3R antagonist, displays 12.5 nM affinity at the hH3R and the highest inhibitory activity against AChE (IC50 = 1.537 μM)[1].

ADSL Human Pre-designed siRNA Set A contains three designed siRNAs for ADSL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADSS1 Human Pre-designed siRNA Set A contains three designed siRNAs for ADSS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADSS2 Human Pre-designed siRNA Set A contains three designed siRNAs for ADSS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADT-007 is a potent and orally active pan-RAS inhibitor with strong anticancer effects. ADT-007 binds RAS in a nucleotide-free conformation to block GTP activation. ADT-007 potently and selectively inhibits the growth of cancer cells with mutated or hyper-activated wild-type RAS isozymes[1].

ADT-007 is a potent and orally active pan-RAS inhibitor with strong anticancer effects. ADT-007 binds RAS in a nucleotide-free conformation to block GTP activation. ADT-007 potently and selectively inhibits the growth of cancer cells with mutated or hyper-activated wild-type RAS isozymes[1].

ADT-007 is a potent and orally active pan-RAS inhibitor with strong anticancer effects. ADT-007 binds RAS in a nucleotide-free conformation to block GTP activation. ADT-007 potently and selectively inhibits the growth of cancer cells with mutated or hyper-activated wild-type RAS isozymes[1].

ADT-007 is a potent and orally active pan-RAS inhibitor with strong anticancer effects. ADT-007 binds RAS in a nucleotide-free conformation to block GTP activation. ADT-007 potently and selectively inhibits the growth of cancer cells with mutated or hyper-activated wild-type RAS isozymes[1].

ADTRP Human Pre-designed siRNA Set A contains three designed siRNAs for ADTRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AE-ITU dihydrobromide is the dihydrobromide form of AE-ITU. AE-ITU dihydrobromide is a selective inhibitor for inducible NO synthase (iNOS), and attenuates the liver dysfunction caused by endotoxaemia in rats[1].

AEBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for AEBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AEBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for AEBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AEN Human Pre-designed siRNA Set A contains three designed siRNAs for AEN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aerothionin is an antibiotic with potent antimicrobial efficacy against bacteria and fungi. Aerothionin exhibits antitumor efficacy against adrenal pheochromocytomas and extra-adrenal paragangliomas (PPGLs)[1][2].

AF 594 azide (triethylamine) is an azide derivative of the red fluorescent dye AF 594, which has high fluorescence quantum yield and high photostability (maximum absorption wavelength of 586 nm, maximum emission wavelength of 613 nm). AF 594 azide (triethylamine) forms stable adducts by reaction of the azide group with alkynyl derivatives (terminal alkynes and […]

AF 594 azide (triethylamine) is an azide derivative of the red fluorescent dye AF 594, which has high fluorescence quantum yield and high photostability (maximum absorption wavelength of 586 nm, maximum emission wavelength of 613 nm). AF 594 azide (triethylamine) forms stable adducts by reaction of the azide group with alkynyl derivatives (terminal alkynes and […]

AF 594 azide (triethylamine) is an azide derivative of the red fluorescent dye AF 594, which has high fluorescence quantum yield and high photostability (maximum absorption wavelength of 586 nm, maximum emission wavelength of 613 nm). AF 594 azide (triethylamine) forms stable adducts by reaction of the azide group with alkynyl derivatives (terminal alkynes and […]

AF299 can reduce collagen-related peptide-induced platelet Ca2+ rises and collagen-induced platelet aggregation. AF299 can be used for research of antiplatelet research[1].

AF488 NHS ester diTEA is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes […]

AFAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for AFAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFAP1L2 Human Pre-designed siRNA Set A contains three designed siRNAs for AFAP1L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFDN Human Pre-designed siRNA Set A contains three designed siRNAs for AFDN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFF1 Human Pre-designed siRNA Set A contains three designed siRNAs for AFF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFF2 Human Pre-designed siRNA Set A contains three designed siRNAs for AFF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFF3 Human Pre-designed siRNA Set A contains three designed siRNAs for AFF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFF4 Human Pre-designed siRNA Set A contains three designed siRNAs for AFF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFFGHYLYEVAR-(Arg-13C6,15N4) is 13C and 15N labeled AFFGHYLYEVAR-(Arg)[1].

AFG3L2 Human Pre-designed siRNA Set A contains three designed siRNAs for AFG3L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aflatoxin B1/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

Aflatoxin B1/KLH is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Aflatoxin B1 (HY-N6615) and KLH. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

AFM Human Pre-designed siRNA Set A contains three designed siRNAs for AFM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFMID Human Pre-designed siRNA Set A contains three designed siRNAs for AFMID gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFP Human Pre-designed siRNA Set A contains three designed siRNAs for AFP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AFP-07 free acid is a derivative of 7, 7-difluoroprostacyclic and is a highly potent and selective prostacyclin receptor IP receptor agonist with a Ki value of 0.561 nM[1].

AG-041R is a potent and selective CCK2 Receptor/Gastrin antagonist. AG-041R inhibits gastrin-evoked secretion of pancreastatin with an IC50 of 2.2 nM. AG-041R inhibits cell growth of Mastomys ECL carcinoid tumor cells[1][2].

AGA Human Pre-designed siRNA Set A contains three designed siRNAs for AGA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for AGAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for AGAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGAP3 Human Pre-designed siRNA Set A contains three designed siRNAs for AGAP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGBL1 Human Pre-designed siRNA Set A contains three designed siRNAs for AGBL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGBL2 Human Pre-designed siRNA Set A contains three designed siRNAs for AGBL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGBL4 Human Pre-designed siRNA Set A contains three designed siRNAs for AGBL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGBL5 Human Pre-designed siRNA Set A contains three designed siRNAs for AGBL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGER Human Pre-designed siRNA Set A contains three designed siRNAs for AGER gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGFG1 Human Pre-designed siRNA Set A contains three designed siRNAs for AGFG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AGFG2 Human Pre-designed siRNA Set A contains three designed siRNAs for AGFG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.